Clinical Trial Results:
Single centre, prospective, comparative, open-label, randomised study to evaluate the efficacy and tolerability of the combination of Moxifloxacin plus Metronidazole versus Piperacillin/Tazobactam for the treatment of patients with intra-abdominal abscesses (MEMO)
Summary
|
|
EudraCT number |
2005-002634-35 |
Trial protocol |
DE |
Global completion date |
04 Jul 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
26 Jan 2020
|
First version publication date |
26 Jan 2020
|
Other versions |
|
Summary report(s) |
Summary Memo study |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.